Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
about
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cellsPPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerMetabolic syndrome and renal cell carcinomaMolecular mechanisms of adenosine-induced apoptosis in human HepG2 cells.Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivoTargeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist.The potential of antidiabetic thiazolidinediones for anticancer therapy.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancerPresent concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.Chondrosarcoma and peroxisome proliferator-activated receptor.Thiazolidinediones as anti-cancer agents.PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Relationship between arachidonic acid pathway and human renal cell carcinoma.Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.New insights into antidiabetic drugs: Possible applications in cancer treatment.Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis.Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 5, 7-dihydroxy-8-nitrochrysin in vitro.Pioglitazone induces apoptosis of macrophages in human adipose tissue.Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells.Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways
P2860
Q21260390-67794CD8-461E-4130-BA31-0E6F78BF7F63Q21328702-F8BF2AC8-2461-4F69-9398-D067C90FFF57Q26825147-123B4592-D15E-40DF-A254-F61FB50E7B79Q33236656-6564B580-B71B-473C-8C1C-DBE188A3958AQ33809071-8B7C6E9A-2CAF-4FBC-9A10-18F74B49B66DQ34565890-20B5DB0A-8448-4ED5-B8FC-7F4C5841D350Q36296641-80ADDC8A-1671-4B24-A491-6A84F2643841Q36392814-4A9DEE78-A09B-4E17-89D0-84C44996DCC0Q36568732-91ACAD4D-68FE-4774-8135-358DFFFD30D7Q36661722-87FD5EA6-87B8-4655-8DF7-D5A2D4F0BDD7Q36795404-9D17A4EB-1938-4941-AE27-E9521ACC2276Q36840323-1CFE8D27-2ED7-4CF7-AA5C-08A27300FB24Q37010188-9858ADAD-1516-45DC-9E2F-8A037ABD294FQ37632735-19914DAB-A8FD-4F85-9457-5A17BC3A43B0Q37656960-7F805DBF-4496-46FD-871B-01AB0DE4CE1CQ37815383-69D7F2CD-1518-4900-89D6-10DC7CE119D4Q38744037-A872D91B-6654-476A-92C0-92E7A33F7957Q38909191-F2150D24-FE39-4A7B-9462-8915127FBC55Q39008676-BB4D1E95-1BF6-49E8-8571-8D29D5038961Q39239818-904CB3C5-4B23-4B52-85A6-2457FF9C3E6EQ39272833-CD798510-FE75-46E3-B9D7-63928A589BF0Q39639581-C0973BDC-A982-4B5A-8441-39463F4C1EC8Q39818168-C48D7CE6-9238-4CCE-8410-55407ACC3FD0Q39992582-E94A280D-F6AA-421F-B183-D224C3FB93C0Q40101615-6D09A34A-1217-41BF-8AD6-8611001CDF9AQ40262958-5E674BF1-725B-4367-8739-C6EC3154F450Q43158772-257B9B4B-78A0-460B-9128-16A1B0C7E4B7Q58796043-97A44C03-C8C9-4595-A484-DA4BFE5FF519
P2860
Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@ast
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@en
type
label
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@ast
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@en
prefLabel
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@ast
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@en
P2093
P2860
P1476
Peroxisome proliferator-activa ...... an renal carcinoma cell lines.
@en
P2093
Chang-jin Shi
Dian-qi Xin
Feng-guang Yang
Jie-ping Wu
Ying-lu Guo
You-fei Guan
Zhi-wen Zhang
P2860
P304
P356
10.1111/J.1745-7254.2005.00753.X
P577
2005-06-01T00:00:00Z
P5875
P6179
1006719537